Overview
ARX-related encephalopathy-brain malformation spectrum is a rare genetic brain disorder caused by changes (mutations) in the ARX gene. ARX stands for Aristaless Related Homeobox, and this gene plays a critical role in the development of the brain before and after birth. The condition is also sometimes referred to as ARX-related disorders or ARX spectrum disorder. Because the ARX gene is located on the X chromosome, this condition primarily affects males, though some females who carry the gene change can have milder symptoms. The disorder can cause a wide range of brain problems, from severe structural malformations of the brain to epilepsy (seizures), intellectual disability, and movement difficulties. Some affected individuals have a condition called lissencephaly (where the brain surface is unusually smooth), while others may have abnormal brain wiring or smaller brain structures. Seizures are very common and can be difficult to control with standard medications. There is currently no cure for ARX-related encephalopathy-brain malformation spectrum. Treatment focuses on managing symptoms, especially seizures, developmental delays, and movement problems. A team of specialists including neurologists, developmental pediatricians, and therapists typically work together to support affected individuals and their families.
Key symptoms:
Seizures that are often hard to control with medicationIntellectual disability ranging from mild to severeDelayed or absent speech and language developmentDelayed motor milestones such as sitting, standing, or walkingAbnormal muscle tone (either too floppy or too stiff)Brain malformations visible on MRI, such as a smooth brain surface (lissencephaly)Movement problems including unsteady walking or involuntary movementsBehavioral challenges such as hyperactivity or aggressionFeeding difficulties in infancySmall head size (microcephaly) in some casesAbnormal eye movements or vision problems
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for ARX-related encephalopathy-brain malformation spectrum.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for ARX-related encephalopathy-brain malformation spectrum at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for ARX-related encephalopathy-brain malformation spectrum.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to ARX-related encephalopathy-brain malformation spectrum.
Community
No community posts yet. Be the first to share your experience with ARX-related encephalopathy-brain malformation spectrum.
Start the conversation →Latest news about ARX-related encephalopathy-brain malformation spectrum
No recent news articles for ARX-related encephalopathy-brain malformation spectrum.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific change was found in the ARX gene, and what does that mean for my child's prognosis?,Which anti-seizure medications are most likely to help, and what are the side effects we should watch for?,Should we consider a ketogenic diet, and how would we get started safely?,What therapies (speech, physical, occupational) should my child be receiving, and how often?,Are there any clinical trials or research studies that my child might be eligible for?,Should other family members, including sisters or the mother, be tested for the ARX gene change?,What emergency plan should we have in place for prolonged or repeated seizures?
Common questions about ARX-related encephalopathy-brain malformation spectrum
What is ARX-related encephalopathy-brain malformation spectrum?
ARX-related encephalopathy-brain malformation spectrum is a rare genetic brain disorder caused by changes (mutations) in the ARX gene. ARX stands for Aristaless Related Homeobox, and this gene plays a critical role in the development of the brain before and after birth. The condition is also sometimes referred to as ARX-related disorders or ARX spectrum disorder. Because the ARX gene is located on the X chromosome, this condition primarily affects males, though some females who carry the gene change can have milder symptoms. The disorder can cause a wide range of brain problems, from severe s
How is ARX-related encephalopathy-brain malformation spectrum inherited?
ARX-related encephalopathy-brain malformation spectrum follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does ARX-related encephalopathy-brain malformation spectrum typically begin?
Typical onset of ARX-related encephalopathy-brain malformation spectrum is neonatal. Age of onset can vary across affected individuals.